Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid, Acute

Explore clinical trials studying Leukemia, Myeloid, Acute. Study availability and eligibility vary by location and protocol.

78 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid, Acute trial results

Completed

Study for Patients With Newly Diagnosed, High-risk Acute Promyelocytic Leukemia

NCT02688140

Conditions
Acute Promyelocytic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations
  • French-Belgian-Swiss APL study group All Participating Sites, France
  • AML-CG study group All Participating Sites, Germany
  • AML-SG study group All Participating Sites, Germany
  • OSHO study group All Participating Sites, Germany
View Trial Details
Completed

(PATHFINDER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients With Advanced Systemic Mastocytosis

NCT03580655

Conditions
Advanced Systemic Mastocytosis, Aggressive Systemic Mastocytosis, Hematologic Diseases, +15 more
Locations
  • Stanford Cancer Institute Stanford, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • The University of Kansas Cancer Center Westwood, Kansas, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 32 locations
View Trial Details
Completed

A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies

NCT02571036

Conditions
Advanced Cancers, Advanced Systemic Mastocytosis, Bronchial Neoplasms, +53 more
Locations
  • Honor Health (GIST, mastocytosis, other solid tumors) Scottsdale, Arizona, United States
  • UCLA Hematology Center (mastocytosis) Los Angeles, California, United States
  • UCLA (glial malignancies only) Los Angeles, California, United States
  • Stanford University Comprehensive Cancer Center (GIST) Palo Alto, California, United States
View all 26 locations
View Trial Details
Completed

(EXPLORER) Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (AdvSM) and Relapsed or Refractory Myeloid Malignancies

NCT02561988

Conditions
Aggressive Systemic Mastocytosis, Disease Attributes, Hematologic Diseases, +19 more
Locations
  • Stanford Cancer Institute Stanford, California, United States
  • University of Colorado Cancer Center Denver, Colorado, United States
  • Emory University Atlanta, Georgia, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions